RegenLab USA LLC

Since 2003, RegenLab® has been committed to the development of a unique expertise in the design and manufacturing of high-quality medical devices, intended for the preparation of cellular therapies and autologous platelet-rich plasma (PRP) from the patient’s own blood. Bringing these technologies to the United States in 2013, RegenLab® USA offers Regen® A-PRP® and Autologous Thrombin Serum with a focus on product quality, patient safety, and preparation efficiency. Now in 2022, RegenLab is proud to be manufactured in the USA. As we look to the future, we are committed to guiding new standards for emerging categories within the field of regenerative medicine.